EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, L&C BIO Co's enterprise value is ₩490,250 Mil.
L&C BIO Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩70,635 Mil. Therefore, L&C BIO Co's EV-to-Revenue for today is 6.94.
The historical rank and industry rank for L&C BIO Co's EV-to-Revenue or its related term are showing as below:
XKRX:290650'
s EV-to-Revenue Range Over the Past 10 Years
Min: 4.16 Med: 13.7 Max: 100.58
Current: 7.15
During the past 9 years, the highest EV-to-Revenue of L&C BIO Co was 100.58. The lowest was 4.16. And the median was 13.70.
XKRX:290650's EV-to-Revenue is ranked worse than 75.06% of 830
companies
in the Medical Devices & Instruments industry
Industry Median: 3.265
vs XKRX:290650: 7.15
As of today (2024-05-22), L&C BIO Co's stock price is ₩20050.00.
L&C BIO Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩3,065.68. Therefore, L&C BIO Co's PS Ratio for today is 6.54.
L&C BIO Co EV-to-Revenue Historical Data
The historical data trend for L&C BIO Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of L&C BIO Co's EV-to-Revenue
For the Medical Devices subindustry, L&C BIO Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
L&C BIO Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, L&C BIO Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where L&C BIO Co's EV-to-Revenue falls into.
L&C BIO Co's current Enterprise Value is ₩490,250 Mil.
L&C BIO Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩70,635 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
L&C BIO Co (XKRX:290650) EV-to-Revenue Explanation
L&C BIO Co's share price for today is ₩20050.00.
L&C BIO Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,065.68.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
L&C BIO Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of L&C BIO Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:290650 has been successfully added to your 